Cardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes
Table 2
Clinical profile of the CAVI and DPN markers ().
CAVI
8.6 ± 1.4
Nerve conduction study
Sural SCV (m/s)
42.3 ± 5.1
Peroneal MCV (m/s)
42.7 ± 4.6
Tibial MCV (m/s)
40.9 ± 4.5
Median FWCV (m/s)
61.9 ± 6.1
Neuropathy (rate of abnormality)
Bilateral foot symptoms (%)
31.9
Decreased Achilles tendon reflex (%)
54.5
Decreased vibration perception (%)
41.6
Decreased touch sensation examined by Semmes–Weinstein monofilaments (%)
38.8
Autonomic symptoms (%)
56.6
Atrophy and muscle weakness of extensor digitorum brevis (%)
13.3
Neuropathy (by the Toronto consensus criteria) (%)
57.6
Neuropathy stage (by the Diabetic Neuropathy Study Group in Japan) (%)
1: 30.7; 2: 20.5; 3: 15.7; 4: 22.3; 5: 10.8
CVR-R
Resting (%)
2.4 ± 1.3
Deep breathing (%)
4.9 ± 2.5
Values are mean ± standard deviation. CAVI: cardio-ankle vascular index; SCV: sensory nerve conduction velocity; MCV: motor nerve conduction velocity; FWCV: F-wave conduction velocity; CVR-R: coefficient of variation of the R-R interval.
